News tagged with vancomycin
The microbiome and disease: Gut bacteria influence the severity of heart attacks in rats
New research published online in the FASEB Journal (http://www.fasebj.org) suggests that the types and levels of bacteria in the intestines may be used to predict a person's likelihood of having a heart attack, and that manipulating ...
Jan 13, 2012 |
not rated yet |
0
|
Researchers closer to the super bug puzzle
Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.
Nov 11, 2011 |
5 / 5 (2) |
0
|
Why did healthy children fall critically ill in the 2009 H1N1 flu pandemic?
During the 2009 H1N1 influenza pandemic, many previously healthy children became critically ill, developing severe pneumonia and respiratory failure, sometimes fatal. The largest nationwide investigation to date of influenza ...
Nov 07, 2011 |
5 / 5 (1) |
1
|
Fecal microbiota transplants effective treatment for C. difficile, Inflammatory Bowel Disease
Growing evidence for the effectiveness of fecal microbiota transplants as a treatment for patients with recurrent bouts of Clostridium difficile (C.difficile) associated diarrhea is presented in three studies -- including ...
Oct 31, 2011 |
not rated yet |
0
Hope for powerful new C diff. treatment
MGB Biopharma, a biopharmaceutical company which has licensed technology from the University of Strathclyde in Glasgow, Scotland, is developing a powerful new antibiotic treatment for resistant infections including the deadly ...
Sep 19, 2011 |
not rated yet |
0
Genomic analysis of superbug provides clues to antibiotic resistance
An analysis of the genome of a superbug has yielded crucial, novel information that could aid efforts to counteract the bacterium's resistance to an antibiotic of last resort. The results of the research led by scientists ...
Sep 08, 2011 |
not rated yet |
0
|
Scientists reengineer antibiotic to overcome dangerous antibiotic-resistant bacteria
A team of scientists from The Scripps Research Institute have successfully reengineered an important antibiotic to kill the deadliest antibiotic-resistant bacteria. The compound could one day be used clinically to treat patients ...
Aug 24, 2011 |
5 / 5 (7) |
1
|
Antibiotic linezolid an effective option for treating patients with MRSA infection
The antibiotic linezolid may be more effective than vancomycin in treating ventilated patients who develop methicillin-resistant Staphylococcus aureus (MRSA) pneumonia as a result of their ventilation, according to a study ...
May 16, 2011 |
not rated yet |
0
Alarming combo: Bedbugs with 'superbug' germ found
Hate insects? Afraid of germs? Researchers are reporting an alarming combination: bedbugs carrying "superbug" germs.
May 11, 2011 |
5 / 5 (3) |
4
Challenges in stemming the spread of resistant bacteria in intensive care
A new research study of the effect of a commonly used strategy to reduce the spread of antibiotic-resistant bacteria in hospital intensive care units (ICU) shows that the strategy had no significant effect. That's the surprising ...
Apr 13, 2011 |
not rated yet |
0
First new C. difficile drug in a generation superior to existing treatments: Researchers
Clostridium difficile infection (CDI) is a significant and growing problem in hospitals and other health care facilities, but no new drugs to treat the condition have been developed in several decades. However, a large-scale, phase ...
Feb 02, 2011 |
not rated yet |
0
Vancomycin is the drug of choice for treating cellulitis
Patients admitted to the hospital for the common bacterial skin infection cellulitis should be treated as a first line of defense with the potent antibiotic drug vancomycin rather than other antibiotics such as penicillin, ...
Oct 23, 2010 |
1 / 5 (1) |
0
Seagulls harbor antibiotic resistant bacteria
Analysis of seagull droppings has revealed that one in ten carry 'superbug' bacteria, resistant to the last-resort antibiotic Vancomycin. Researchers writing in BioMed central's open access journal Proteome Science invest ...
Sep 20, 2010 |
not rated yet |
0
Researcher discovers new 'anti-pathogenic' drugs to treat MRSA
Menachem Shoham, PhD, associate professor and researcher in the department of biochemistry at the Case Western Reserve University School of Medicine, has identified new anti-pathogenic drugs that, without killing the bacteria, ...
Sep 16, 2010 |
5 / 5 (4) |
0
hVISA linked to high mortality: study
A MRSA infection with a reduced susceptibility to the potent antibiotic drug vancomycin is linked to high mortality, according to a Henry Ford Hospital study.
Sep 12, 2010 |
4.5 / 5 (2) |
0
Vancomycin
Vancomycin (INN) (pronounced /ˌvæŋkɵˈmaɪsɪn/) is a glycopeptide antibiotic used in the prophylaxis and treatment of infections caused by Gram-positive bacteria. It has traditionally been reserved as a drug of "last resort", used only after treatment with other antibiotics had failed, although the emergence of vancomycin-resistant organisms means that it is increasingly being displaced from this role by linezolid and daptomycin.
For more information about Vancomycin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
